Literature DB >> 2768475

Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid.

L S Siegel1.   

Abstract

Twenty-five serum specimens from personnel immunized with botulinum pentavalent toxoid (ABCDE) had titers of neutralizing antibodies to type A (5.7 to 51.6 IU/ml), type B (0.75 to 18 IU/ml), and type E (0.61 to 10 IU/ml) botulinum toxins. Titers for one type could not be used to predict titers for another type in individuals receiving the toxoid. Cross-neutralizing antibodies to type F botulinum toxin were not detected (less than 0.0125 IU/ml).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2768475      PMCID: PMC267699          DOI: 10.1128/jcm.27.8.1906-1908.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  STUDIES ON IMMUNITY TO TOXINS OF CLOSTRIDIUM BOTULINUM. IX. IMMUNOLOGIC RESPONSE OF MAN TO PURIFIED PENTAVALENT ABCDE BOTULINUM TOXIOD.

Authors:  M A FIOCK; M A CARDELLA; N F GEARINGER
Journal:  J Immunol       Date:  1963-05       Impact factor: 5.422

2.  Preliminary report on the isolation of an apparently new type of CI. botulinum.

Authors:  V MOLLER; I SCHEIBEL
Journal:  Acta Pathol Microbiol Scand       Date:  1960

3.  Clostridium botulinum type F: isolation from venison jerky.

Authors:  T F Midura; G S Nygaard; R M Wood; H L Bodily
Journal:  Appl Microbiol       Date:  1972-08

4.  Characteristics of Clostridium botulinum type F isolated from the Pacific Coast of the United States.

Authors:  M W Eklund; F T Poysky; D I Wieler
Journal:  Appl Microbiol       Date:  1967-11

5.  Type F infant botulism.

Authors:  R E Hoffman; B J Pincomb; M R Skeels
Journal:  Am J Dis Child       Date:  1982-03

6.  Studies on strain 84 of Clostridium botulinum.

Authors:  D F Giménez; A S Ciccarelli
Journal:  Zentralbl Bakteriol Orig       Date:  1970

7.  [First outbreak of botulism caused by Clostridium botulinum subtype Af].

Authors:  R A Fernández; A S Ciccarelli; G N Arenas; D F Giménez
Journal:  Rev Argent Microbiol       Date:  1986       Impact factor: 1.852

8.  Examination of feces and serum for diagnosis of infant botulism in 336 patients.

Authors:  C L Hatheway; L M McCroskey
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

9.  Purification and properties of Clostridium botulinum type F toxin.

Authors:  K H Yang; H Sugiyama
Journal:  Appl Microbiol       Date:  1975-05

10.  Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.

Authors:  C L Hatheway
Journal:  Appl Environ Microbiol       Date:  1976-02       Impact factor: 4.792

  10 in total
  6 in total

1.  Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.

Authors:  Daniel M Held; Amy C Shurtleff; Scott Fields; Christopher Green; Julie Fong; Russell G A Jones; Dorothea Sesardic; Roland Buelow; Rae Lyn Burke
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

2.  Enzyme-linked immunosorbent assay-enzyme-linked coagulation assay for detection of antibodies to Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes.

Authors:  G J Doellgast; M X Triscott; G A Beard; J D Bottoms
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

3.  Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A.

Authors:  G L Sheean; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

4.  [First use of botulinum toxin type B in ENT patients with secondary therapy failure of botulinum toxin type A].

Authors:  O Guntinas-Lichius
Journal:  HNO       Date:  2003-06-17       Impact factor: 1.284

5.  New equine antitoxins to botulinum neurotoxins serotypes A and B.

Authors:  D Li; P Mattoo; J E Keller
Journal:  Biologicals       Date:  2012-05-05       Impact factor: 1.856

Review 6.  Antibodies and Vaccines against Botulinum Toxins: Available Measures and Novel Approaches.

Authors:  Christine Rasetti-Escargueil; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2019-09-12       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.